Tivic expands bioelectronic portfolio; files patent application for new approach to non-invasive vagus nerve stimulation

San francisco--(business wire)--tivic health® systems, inc. (“tivic health”, nasdaq: tivc), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it has filed its first patent in vagus nerve stimulation with the u.s. patent office (uspto), expanding its intellectual property portfolio into new clinical targets. tivic's prior patents and current products have focused on the trigeminal and sympathetic nerve structures.
TIVC Ratings Summary
TIVC Quant Ranking